Stock comparison

UTHRvsVRTX

United Therapeutics CorpvsVertex Pharmaceuticals Inc. Real data pulled from the alphactor.ai fundamentals pipeline — valuation, balance-sheet health, momentum, and analyst sentiment side by side.

UTHR

United Therapeutics Corp

$572.85

+15.96%

Biotechnology$23.1BNASDAQ

VRTX

Vertex Pharmaceuticals Inc

$435.1

-4.37%

Biotechnology$119.2BNASDAQ

60-day price, rebased to 100

UTHR +22.59% · VRTX -7.41%

Round-by-round

UTHR 5·VRTX 1

EdgeUTHR

Valuation upside

-10.40% vs -43.10% to DCF fair value

EdgeUTHR

Balance-sheet strength

Altman Z 20.69 vs 12.39

EdgeUTHR

Fundamental quality

Piotroski 7.00 vs 6.00 (of 9)

EdgeUTHR

Growth + margins

Rule-of-40 43.10 vs 35.50

EdgeUTHR

60-day momentum

+22.59% vs -7.41% price return

EdgeVRTX

Market-cap liquidity

$23.1B vs $119.2B

Verdict

Across6categories,UTHRtakes the edge with5wins to1. Neither score is a buy signal on its own: run the full backtest and credibility tests on alphactor.ai before putting money on it.

Backtest a strategy onUTHRorVRTX

Point-in-time backtests, 8-layer credibility pipeline, conviction scoring — free to start.